Unfortunately, Fluvastatin alone won't clear the virus completely, but it may offer another tool in the treatment arsenal for hepatitis C, especially for those not responding well to conventional therapy. As it is now, only about 50% of people respond well to treatment. Read about two people's experience with the current treatment regimen.
One of the nice benefits of using older medicines for newer treatments, besides the obvious cost savings of researching a new drug, is the established safety record. Fluvastatin has been on the market since 1993, and literally millions have taken it safely. It's now in a phase II trial to see if it can provide stronger results by combining it with the standard pegylated interferon and ribavirin. For more about treatment, check out this overview.



About 135,400 new cases of colorectal cancer will be diagnosed in the United States this year and 56,700 patients will die. Early detection can be a Lifesaver.